Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)

NCT04730635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Mild Cognitive Impairment

Interventions

DRUG: Donepezil
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC